Evaluation of the New Laser PHOTOLASE PLV-585nm for the Treatment of Rosacea

Inclusion Criteria: * Fitzpatrick Skin Type I - III * Post-menopausal or surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrolment and during the entire course of the study. * Clinical diagnosis of Erythematotelangiectatic Rosacea stade II * Homogeneous extend and staining telangiectasia in each half face * Patient never treated with laser for Rosacea * Patient doesn't wish to use systemic corticosteroids or retinoids; or topical corticosteroids or retinoids on the treated area. * Patient agreeing to have limited exposure to the sun and use of a protective screen (index 50 or higher) every day of the study and throughout its duration if it takes place from May to September. * Patient must be able to read, understand and sign the Informed Consent Form * Patient able to adhere to the program of visits of the study and the other imperatives of the protocol * Patient accepting to have photographs taken on the face * Quality of social insurance or social security entitlement Exclusion Criteria: * Pregnant and/or breastfeeding woman or childbearing age without effective contraception * Alcohol abuse assessed at the discretion of the investigator * History of prior laser or light based procedures for any other pathology for the face within 6 months of study participation Fitzpatrick Type IV à VI * Systemic use of isotretinoin in the 6 months prior to inclusion in the study. * Topical use of retinoids and / or corticosteroids…